TY - JOUR
T1 - The role of optic nerve blood flow in the pathogenesis of glaucoma
AU - Harris, Alon
AU - Rechtman, Ehud
AU - Siesky, Brent
AU - Jonescu-Cuypers, Christian
AU - McCranor, Lynne
AU - Garzozi, Hana J.
N1 - Funding Information:
This article was supported by an unrestricted grant from Research to Prevent Blindness.
PY - 2005/9
Y1 - 2005/9
N2 - Although IOP reduction remains the primary goal of POAG therapy, increasing evidence shows that other considerations, including vascular factors leading to ischemia, may contribute to disease initiation or progression. At present, we lack longitudinal, prospective, and randomized trials regarding the effect of ocular blood flow on POAG prognosis. If such studies show a protective effect against POAG, they will open a new era in glaucoma management.
AB - Although IOP reduction remains the primary goal of POAG therapy, increasing evidence shows that other considerations, including vascular factors leading to ischemia, may contribute to disease initiation or progression. At present, we lack longitudinal, prospective, and randomized trials regarding the effect of ocular blood flow on POAG prognosis. If such studies show a protective effect against POAG, they will open a new era in glaucoma management.
UR - http://www.scopus.com/inward/record.url?scp=23044436202&partnerID=8YFLogxK
U2 - 10.1016/j.ohc.2005.04.001
DO - 10.1016/j.ohc.2005.04.001
M3 - Review article
C2 - 16054992
AN - SCOPUS:23044436202
SN - 0896-1549
VL - 18
SP - 345
EP - 353
JO - Ophthalmology Clinics of North America
JF - Ophthalmology Clinics of North America
IS - 3
ER -